|
|
|
|
|
|
| #632 Oral glutamine reduces duration and severity of stomatitis after chemotherapy Anderson, P. M.; Schroeder, G.; Skubitz, K. M. Journal of Pediatric Hematology/Oncology, 1997, p379 |
|
| A Biological Approach to Mucositis Stephen T. Sonis, DMD, DMS TheJournal of Supportive Oncolog, 2004, vol 2, No. 1, pp21-36 |
|
| Amino Acid Supplements MEDITEXT® Medical Managements © 1974-2005 Thomson MICROMEDEX. |
|
| Analysis of Factors That Correlate With Mucositis in Recipients of Autologous and
Allogeneic Stem-Cell Transplants Aaron P. Rapoport, Luc F. Miller Watelet, Tammy Linder, et al J Clin Oncol 17:2446-2453. |
|
| Cancer Treatment-Related Mucositis: Clinical Trials in Supportive Care TheJournal of Supportive Oncolog, 2004, vol 2, No. 1, pp95-96 |
|
| Chronic radiation enteritis: Women´s food tolerances after radiation treatment for
gynecologic cancer. Satnam Sekhon, RDN Journal of the American Dietetic Association; Aug 2000; 100, 8; Health Module p. 941 |
|
| Cytoprotection in Head and Neck Cancer: Issues in Oral Care Michael A. Samuels, MD The Journal OF Supportive Oncology, 2004, vol 2, Supp. 3 pp9-12 |
|
| Effect of Glutamine on Methotrexate Efficacy and Toxicity Rubio, Isabel T. MD; Cao, Yihong MS; Hutchins, Laura F. MD†; Westbrook, Kent C. MD; Klimberg, V. Suzanne MD Annal of Surgery, 1998, vol 227, pp772-780 |
|
| Effect of Glutamine Supplementation on Diarrhea, Interleukin-8 and Secretory
Immunoglobulin A in Children With Acute Diarrhea S. Songu¨l Yalc¸ın, Kadriye Yurdako¨k, Ilhan Tezcan, and Levent Öner Journal of Pediatric Gastroenterology and Nutrition 38:494–501 © May 2004 |
|
| Effects of Glutamine Supplements and Radiochemotherapy on Systemic Immune and Gut
Barrier Function in Patients With Advanced Esophageal Cancer Yoshida, Shogo MD; Matsui, Masasuke MD; Shirouzu, Yuichirou MD, et al Annal of Surgery, 1998, vol 227, pp485-491 |
|
| Erythropoietic Agents in the Management of Cancer Patients Part 2: Studies on Their
Role in Neuroprotection and Neurotherapy Robert E. Smith, Jr., MD The Journal of Supportive Oncology, 2004, vol 2, No. 1, pp39-49 |
|
| MARTINDALE - The Complete Drug Reference, Glutamic Acid 2005 |
|
| MARTINDALE en Español - Guìa Completa de Consulta Fármaco terapéutica ÁCIDO GLUTÁMICO 2005 Pharma Editores, S.L. |
|
| AltMedDex® Summary Glutamina | |
| Glutamine attenuates lung injury and improves survival after sepsis: Role of enhanced
heat shock protein expression Kristen D. Singleton, BS; Natalie Serkova, PhD; Virgina E. Beckey, MS; Paul E. Wischmeyer, MD Crit Care Med 2005 Vol. 33, No. 6 |
|
| Prevention and Treatment of Oropharyngeal Mucositis Following Cancer Therapy Are There
New Approaches? Karis K. F. Kwong, PhD, RN Cancer Nursing™, Vol. 27, No. 3, 2004 |
|
| Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute
Diarrhea in Patients Receiving Pelvic Radiation Therapy Timothy F. Kozelsky, Gregory E. Meyers, Jeff A. Sloan, et al J Clin Oncol 21:1669-1674. © 2003 |
|
| Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients
Receiving Fluorouracil (5-FU)-Based Chemotherapy American Journal of Clinical Oncology Vol 22, 1999, pp 258-261 |
|
| AltMedDex® Evaluations, Glutamina © 1974-2005 Thomson MICROMEDEX. |
|
| Glutamine and the gastrointestinal tract Thomas R. Zieglera, Niloofar Bazargana, Lorraine M. Leadera and Robert G. Martindaleb Curr Opin Clin Nutr Metab Care 3:355±362. # 2000 Lippincott Williams & Wilkins. |
|
| Glutamine clinical applications and mechanisms of action Josef Neu, Vincent DeMarco and Nan Li Curr Opin Clin Nutr Metab Care 5:69±75. # 2002 Lippincott Williams & Wilkins. |
|
| DrugPoint® Summary, Glutamina © 1974-2005 Thomson MICROMEDEX. |
|
| Glutamine- recent developments in research on the clinical significance of glutamine Gerdien C. Melis, Nathalie ter Wengel, Petra G. Boelens and Paul A.M. van Leeuwen Curr Opin Clin Nutr Metab Care 7:59–70. # 2004 Lippincott Williams & Wilkins. |
|
| Glutamine supplementation in bone marrow transplantation Ziegler T. Top Clin Nutr 2002;17(4):83–85 |
|
| Glutamine Supplementation in Cancer Patients Receiving Bone Marrow Transplantation and
High Dose Chemotherapy Thomas R. Ziegler J. Nutr. 131: 2578S-2584S, 2001. |
|
| USP DI® Drug Information for the Health Care Professional, GLUTAMINE (SYSTEMIC) Copyright 1974 - 2005. Thomson MICROMEDEX. |
|
| Glutamine: commercially essential or conditionally essential? A critical appraisal of
the human data Alan L Buchman Am J Clin Nutr 2001;74:25–32. |
|
| GLUTAMINE_and_CANCER Wiley W. Souba, MD, Sc.D. Annals of Surgery, Vol 218, No. 6, pp715-728 |
|
| Emerging evidence of the effectiveness of Glutamine as a protectant against Taxol (paclitaxel)
Injection-induced myalgia/arthralgia and neurotoxicity Linda Vahdat, MD |
|
| Glutamine-clinical applications and mechanisms of action Josef Neu, Vincent DeMarco and Nan Li Curr Opin Clin Nutr Metab Care 5:69±75. # 2002 Lippincott Williams & Wilkins. |
|
| Intestinal Alkalization As a Possible Preventive Mechanism in Irinotecan (CPT-11)-induced
Diarrhea Tadashi Ikegami, Linan Ha, Kazuhiko Arimori, Patricia Latham, et al CANCER RESEARCH 62, 179–187, January 1, 2002 |
|
| AltMedDex - Protocols Leukemia © 1974-2005 Thomson MICROMEDEX. |
|
| 1974-2005 Thomson MICROMEDEX. |
|
| Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour
Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group David H. Moore, James Donnelly, William P. McGuire, et al J Clin Oncol 21:4207-4213. © 2003 |
|
| AltMedDex® Protocols - LUNG CANCER © 1974-2005 Thomson MICROMEDEX. |
|
| Managing Hematologic Toxicities Gerardo Capo, MD, and Roger Waltzman, MD The Journal of Supportive Oncology, 2004, vol 2, No. 1, pp65-79 |
|
| Managing Toxicities in pelvic malignancies Jay Friedland, MD The Journal of Supportive Oncology, 2004, vol 2, supp 3, pp19-23 |
|
| Mechanisms for Radiation-induced Oral Mucositis and the Consequences Aishan Shih, RN, MS Christine Miaskowski, RN, PhD, FAAN, et al Cancer Nursing™, Vol. 26, No. 3, 2003 |
|
| Prevention and Treatment of Oropharyngeal Mucositis Following Cancer Therapy Are There
New Approaches? Karis K. F. Kwong, PhD, RN Cancer Nursing™, Vol. 27, No. 3, 2004 |
|
| Palliation of Oral Mucositis Symptoms in Pediatric Patients Treated With Cancer
Chemotherapy K.K.F. Cheng, RN, PhD, A.M. Chang, RN, PhD Cancer Nursing™, Vol. 26, No. 6, 2003 |
|
| New Paradigms for Treating Elderly Patients With Cancer: The Comprehensive Geriatric
Assessment and Guidelines for Supportive Care Lodovico Balducci, MD The Journal of Supportive Oncology, 2004, vol 1, supp 2, pp30-37 |
|
| Non-Small Cell Lung Cancer The Role of Cytoprotection in Treating Therapy-Related Toxicity Ramesh Gopal, MD, PhD The Journal of Supportive Oncology, 2004, vol 2, supp 3, pp13-17 |
|
| Oral Mucositis in Cancer Therapy Stephen T. Sonis, DMD, DMSc The Journal of Supportive Oncology, 2004, vol 2, supp 3, pp3-8 |
|
| Phase II Study of Activated Charcoal to Prevent Irinotecan-Induced Diarrhea Michael Michael, MaryAnne Brittain, Jane Nagai, et al Journal of clinical oncology, vol 22, No 21, 2004, pp 4410-4417 |
|
| Reduction of Paclitaxel-induced Peripheral Neuropathy with glutamine Linda Vahdat,2 Kyriakos Papadopoulos, et al Clinical Cancer Research Vol. 7, 1192–1197, May 2001 |
|
| Regulative capacity of glutamine Rudolf Oehler and Erich Roth Curr Opin Clin Nutr Metab Care 6:277–282. # 2003 Lippincott Williams & Wilkins. |
|
| Research advances in oral mucositis Peterson, Douglas E. DMD, PHD Currento Opinion in Onclology, Vol. 11, 1999, p261 |
|
| Sex Differences in Fluorouracil-Induced Stomatitis Jeff A. Sloan, Charles L. Loprinzi, Paul J. Novotny, et al J Clin Oncol 18:412-420. © 2000 |